Ryan Mathew is an Associate Professor at the University of Leeds and an Honorary Consultant Neurosurgeon at Leeds Teaching Hospitals. His clinical practice covers the full spectrum of general neurosurgery with a subspecialty interest in brain tumours; in particular gliomas, meningiomas and awake surgery.
After completing his PhD in Glioma Stem Cells and Organoids, and spending time at the Brain Tumour Research Centre at Sickkids in Toronto, he began co-leading the Stem Cells and Brain Tumour Lab Group where his focus is on translational approaches to technologies that deliver local therapeutic treatments.
As Neurosurgery Lead for the NIHR Surgical MedTech Cooperative, NIHR Surgical Technologies Academy Incubator and Royal College of Surgeons of England Leeds Institute of Clinical Trials Research, he also leads a research portfolio in surgical technologies and devices which encompasses virtual/mixed reality, machine learning/AI, real-time intra-operative tumour visualisation and histology, and local therapeutic delivery. He is Health Lead for Leeds XR, the Basic/Translational Science Lead for the Academic Committee of the Society of British Neurological Surgeons, member of the British Neuro-Oncology Society Research Subcommittee, a HoloMedicine Association Founding Member and Core Committee member of the Tessa Jowell Brain Cancer Mission Novel Therapeutics Accelerator.
He has published numerous papers, is an internationally invited speaker and teaching faculty, peer-reviews for a number of journals and grant award committees, and has obtained > £8M in grant funding (PI or Co-I).